Spontaneous contractions of myometrium from humans, non-human primate and rodents are sensitive to selective oxytocin receptor antagonism in vitro

Kimura, 1996, Expression of oxytocin receptor in human pregnant myometrium, Endocrinol, 137, 780, 10.1210/en.137.2.780 Takemura, 1994, Expression and localization of human oxytocin receptor mRNA and its protein in chorion and decidua during parturition, J Clin Invest, 93, 2319, 10.1172/JCI117236 Maggi, 1990, Human myometrium during pregnancy contains and responds to V1 vasopressin receptors as well as oxytocin receptors, J Clin Endocrinol Metab, 70, 1142, 10.1210/jcem-70-4-1142 Rezapour, 1996, Myometrial steroid concentration and oxytocin receptor density in parturient women at term, Steroids, 61, 339, 10.1016/0039-128X(96)00035-9 Fuchs, 1991, Oxytocin secretion and human parturition: pulse frequency and duration increase during spontaneous labour in women, Am J Obstet Gynecol, 165, 1515, 10.1016/S0002-9378(12)90793-0 Thornton, 1992, Plasma oxytocin during the first and second stages of spontaneous human labour, Acta Endocrinol (Copenh), 126, 425, 10.1530/acta.0.1260425 Chibbar, 1993, Synthesis of oxytocin in amnion, chorion, and decidua may influence the timing of human parturition, J Clin Invest, 91, 185, 10.1172/JCI116169 Miller, 1993, Synthesis of oxytocin in amnion, chorion and decidua: a potential paracrine role for oxytocin in the onset of human myometrium, Regul Peptides, 45, 247, 10.1016/0167-0115(93)90214-S Kinsler, 1996, The effect of oxytocin antagonists F314 and F792 on the in vitro contractility of human myometrium, Br J Obstet Gynaecol, 103, 373, 10.1111/j.1471-0528.1996.tb09745.x Goodwin, 1994, The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human, Am J Obstet Gynecol, 170, 474, 10.1016/S0002-9378(94)70214-4 Zeeman, 1997, Oxytocin and its receptor in pregnancy and parturition: current concepts and clinical implications, Obstet Gynecol, 89, 873, 10.1016/S0029-7844(97)00056-2 Goodwin, 1996, Treatment of preterm labour with the oxytocin antagonist atosiban, Am J Perinatol, 13, 143, 10.1055/s-2007-994312 Romero, 2000, An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue, Am J Obstet Gynecol, 182, 1173, 10.1067/mob.2000.95834 Moutquin, 2000, Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study, Am J Obstet Gynecol, 182, 1191, 10.1067/mob.2000.104950 Akerlund, 1999, Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women, Br J Obstet Gynaecol, 106, 1047, 10.1111/j.1471-0528.1999.tb08112.x Williams, 1995, 1-(1-[4-[(N-acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4- yl)-4H- 3,1-benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist, J Med Chem, 38, 4634, 10.1021/jm00023a002 Melin, 1986, Synthetic antagonists of the myometrial response to vasopressin and oxytocin, J Endocrinol, 111, 125, 10.1677/joe.0.1110125 Allen, 1997 Chan, 1974, Inhibition of oxytocic responses to oxytocin in pregnant rats by [1-L-penicillamine]-oxytocin, Proc Soc Exp Biol Med, 146, 364, 10.3181/00379727-146-38105 Pettibone, 1989, structurally unique, potent and selective oxytocin antagonist derived from Streptomyces silvensis, Endocrinol, 125, 217, 10.1210/endo-125-1-217 Crankshaw, 1997, Attempts to estimate location parameters for complex concentration-effect curves in human myometrium, Br J Pharmacol, 122, 134 Bossmar, 1994, Receptors for and myometrial responses to oxytocin and vasopressin in preterm and term human pregnancy: effects of the oxytocin antagonist atosiban, Am J Obstet Gynecol, 171, 1634, 10.1016/0002-9378(94)90415-4 Maggi, 1994, Antagonists for the human oxytocin receptor: an in vitro study, J Reprod Fertil, 101, 345, 10.1530/jrf.0.1010345 Pettibone, 1995, Progress in the development of oxytocin antagonists for use in preterm labour, Adv Exp Med Biol, 395, 601 Egerman, 1995, The oxytocin receptor antagonist L-368,899 inhibits stimulated uterine contractions in women during the post partum period, Am J Obstet Gynecol, 172, 414, 10.1016/0002-9378(95)91253-3 Brailoiu, 1999, Contractile effects by intracellular angiotensin II via receptors with a distinct pharmacological profile in rat aorta, Br J Pharmacol, 126, 1133, 10.1038/sj.bjp.0702421 Bhattacharya, 1999, Localization of functional prostaglandin E-2 receptors EP3 and EP4 in the nuclear envelope, J Biol Chem, 274, 15719, 10.1074/jbc.274.22.15719 Lefkowitz, 1993, Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins, Trends Pharmacol Sci, 14, 303, 10.1016/0165-6147(93)90048-O Chini, 1998, Identification of a constitutively active mutant of the human oxytocin receptor, Adv Exp Med Biol, 449, 367, 10.1007/978-1-4615-4871-3_47 Thornton, 1995, Myometrial oxytocin messenger RNA is not increased at the onset of human labour, Adv Exp Med Biol, 395, 551 Milligan, 1997, Inverse agonism at adrenergic and opioid receptors: studies with wild type and constitutively active mutant receptors, Receptor Channels, 5, 209 Cheng, 1973, Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (IC50) of an enzyme reaction, Biochem Pharmacol, 22, 3099, 10.1016/0006-2952(73)90196-2